Concepedia

Author

Ruyue Xu

Anhui University of Science and TechnologyORCID

Also Known As

Ruyue Xu

30

Publications

420

Citations

13

H-Index

23

Concepts

All Affiliations

Anhui University of Science and TechnologyFirst Affiliated Hospital of Bengbu Medical CollegeZhejiang UniversityJinan UniversityGuangzhou Medical University
RX

About

Ruyue Xu is an author at Anhui University of Science and Technology specializing in cell biology, medicine, and cancer biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

127

2

Cell Biology

4

4

127

3

Health Sciences

1

1

30

4

Immunology

1

1

34

5

Pathology

1

1

44

Ruyue Xu

×

14

Publications

360

Citations

12

H-Index

YearCitations

PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.

Yinci Zhang, Chunmei Xie, Amin Li,

PubMed

2019

44

Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3

Weiya Cao, Yinci Zhang, Amin Li,

Toxicology Mechanisms and Methods

2021

40

LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells

Yongfang Ma, Ruyue Xu, Xueke Liu,

International Journal of Medical Sciences

2021

36

c-Met up-regulates the expression of PD-L1 through MAPK/NF-κBp65 pathway

Ruyue Xu, Xinkuang Liu, Amin Li,

Journal of Molecular Medicine

2022

34

BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.

Amin Li, Rongbo Zhang, Yinci Zhang,

PubMed

2019

32

LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway

Ruyue Xu, Yinci Zhang, Amin Li,

Molecular Medicine Reports

2021

30

BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway.

Xueke Liu, Chunmei Xie, Amin Li,

PubMed

2019

26

BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy

Weiya Cao, Xueke Liu, Yinci Zhang,

BioMed Research International

2021

24

hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway

Jing Shen, Wenpeng Cai, Yongfang Ma,

Nanoscale Research Letters

2020

23

RETRACTED ARTICLE: The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway

Xiaolong Tang, Amin Li, Chunmei Xie,

Nanoscale Research Letters

2020

19

Page 1